Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours

被引:180
作者
Bettini, R. [1 ]
Boninsegna, L. [1 ]
Mantovani, W. [2 ]
Capelli, P. [3 ]
Bassi, C. [1 ]
Pederzoli, P. [1 ]
Delle Fave, G. F. [4 ]
Panzuto, F. [4 ]
Scarpa, A.
Falconi, M. [1 ]
机构
[1] Univ Verona, Dept Surg & Gastroenterol Sci, I-37100 Verona, Italy
[2] Univ Verona, Dept Med & Publ Hlth, I-37100 Verona, Italy
[3] Univ Verona, Dept Pathol, I-37100 Verona, Italy
[4] Univ Roma La Sapienza, Sch Med 2, Dept Digest & Liver Dis, Rome, Italy
关键词
pancreatic endocrine tumours; pancreatic neoplasm; pancreatic surgery; prognostic factors; survival;
D O I
10.1093/annonc/mdm552
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Non- functioning pancreatic endocrine tumours ( NF- PETs) are an aggressive gastroenteropancreatic neoplasm. The present study assessed survival, value of World Health Organisation ( WHO) classification and prognostic utility of clinicopathological parameters at diagnosis. Patients and methods: From 1990 to 2004, 180 patients with NF- PETs were entered in a prospective database, and predictors of prognosis were tested in uni- and multivariate models. Results: There were 25 ( 14%) benign lesions, 38 ( 21%) neoplasms of uncertain behaviour, 100 well- differentiated carcinomas ( 56%) and 17 poorly differentiated carcinomas ( 9%). Radical resection was possible in 93 cases ( 51.6%). Overall 5-, 10- and 15- year survival rates were 67%, 49.3% and 32.8%, respectively, and were significantly higher in radically resected patients ( 93%, 80.8% and 65.2%, respectively; P < 0.00001). By multivariate analysis, poor differentiation [ hazard ratio ( HR) 7.3; P = 0.0001], nodal metastases ( HR 3.05; P = 0.02), liver metastases ( HR 3.29; P = 0.003), K(i)- 67 > 5% ( HR 2.5; P = 0.012) and weight loss ( HR 3.06; P = 0.001) were significantly associated with mortality. Conclusion: This study confirms the good long- term survival of patients with NF- PETs and the prognostic value of WHO classification, liver metastases, poor differentiation, Ki- 67, nodal metastases and weight loss. These latter two parameters have a prognostic value similar to that of liver metastases and Ki- 67.
引用
收藏
页码:903 / 908
页数:6
相关论文
共 27 条
  • [1] [Anonymous], 2004, PATHOLOGY GENETICS T
  • [2] Management of nonfunctioning islet cell carcinomas
    Bartsch, DK
    Schilling, T
    Ramaswamy, A
    Gerdes, B
    Celik, I
    Wagner, HJ
    Simon, B
    Rothmund, M
    [J]. WORLD JOURNAL OF SURGERY, 2000, 24 (11) : 1418 - 1424
  • [3] Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma
    Butturini, G.
    Bettini, R.
    Missiaglia, E.
    Mantovani, W.
    Dalai, I.
    Capelli, P.
    Ferdeghini, M.
    Pederzoli, P.
    Scarpa, A.
    Falconi, M.
    [J]. ENDOCRINE-RELATED CANCER, 2006, 13 (04) : 1213 - 1221
  • [4] Predictive factors associated with long-term survival in patients with neuroendocrine tumors of the pancreas
    Chu, QD
    Hill, HC
    Douglass, HO
    Driscoll, D
    Smith, JL
    Nava, HR
    Gibbs, JF
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2002, 9 (09) : 855 - 862
  • [5] Molecular insights into gastrointestinal neuroendocrine tumours: importance and recent advances
    Corleto, VD
    Delle Fave, G
    Jensen, RT
    [J]. DIGESTIVE AND LIVER DISEASE, 2002, 34 (09) : 668 - 680
  • [6] Gastro-intestinal endocrine tumors: morphological and clinicopathological characteristics
    Couvelard, A
    [J]. ANNALES DE PATHOLOGIE, 2005, 25 (06) : 499 - 509
  • [7] EVANS DB, 1993, SURGERY, V114, P1175
  • [8] EVANS DB, 1993, SURGERY, V1114, P1181
  • [9] Role of chemoembolization in synchronous liver metastases from pancreatic endocrine tumours
    Falconi, M
    Bassi, C
    Bonora, A
    Sartori, N
    Procacci, C
    Talamini, G
    Mansueto, GC
    Pederzoli, P
    [J]. DIGESTIVE SURGERY, 1999, 16 (01) : 32 - 38
  • [10] Well-differentiated pancreatic nonfunctioning tumors/carcinoma
    Falconi, Massimo
    Ploeckinger, Ursula
    Kwekkeboom, Dik J.
    Manfredi, Riccardo
    Koerner, Meike
    Kvols, Larry
    Pape, Ulrich F.
    Ricke, Jens
    Goretzki, Peter E.
    Wildi, Stefan
    Steinmueller, Thomas
    Oberg, Kjell
    Scoazec, Jean-Yves
    [J]. NEUROENDOCRINOLOGY, 2006, 84 (03) : 196 - 211